Throughout the world mental illnesses are on the rise: Every third sick leave is due to psychological reasons. This poses a threat of a cost explosion in the healthcare sector, that insurance companies and health authorities are trying to counteract.
Doctors and psychologists want to help their patients as best as they can. In order to do this, they must understand the individual disease. Three quarters of the symptoms are not directly visible but can only be reported by patients.
Mental illnesses affect the whole person and all areas of psychological disorders would have to be systematically addressed by a specialist. Today dozens of disorder areas involving hundreds of interwoven symptoms are known, which makes comprehensive diagnostics under time and cost aspects hardly manageable. Doctors are faced with the challenge of providing a diagnosis and simultaneously starting therapy.
The problem is exacerbated by the fact that psychiatrists and psychotherapists have high quality specialised training, enabling them to effectively treat different types of mental illnesses. It is therefore important that patients are referred to a suitable specialist right away. This ensures efficient and effective treatment and counteracts the threat of a cost explosion.
To sum up: The number of patients is rising. In some places, patients already have to wait up to 3 months for an initial appointment, which is clearly too long for an acute illness. However, the number of psychiatrists and psychotherapists is limited, and it is important to avoid overloading them.
The Swiss start-up Klenico has developed a web-based certified medical product that provides doctors and therapists with versatile assistance and a solution to the problems described above:
- The Klenico system provides visual findings that provide insight quickly and at a glance.
- It covers the full range of mental disorders.
- It is based on the worldwide standards of the DSM and ICD.
- Valuable resources of doctors and therapists are spared.
- Patients are actively involved.
- Changes and treatment successes become visible.
- Symptoms reports can be shared.
25 years ago
Dr. Damian Läge starts in Zurich his research on psychometric methods. As one of the world’s leading experts in the area of nonmetric multidimensional scaling (NMDS), he enables the its use in the psychiatric field.
Prof. Dr. Damian Läge launches at the University of Zurich a project with the aim of applying algorithms to structure psychopathological symptoms. Under the patronage of Prof. Dr. Hans-Jürgen Möller, a re-analysis of the world’s largest AMDP data set (AMDP = Manual for Assessment and Documentation of Psychopathology in Psychiatry) is conducted.
Damian Läge and his team of researchers succeed in uncovering data structures that before could not be detected using conventional factor-analytical methods. Europe’s most renowned journal for psychology publishes these results (Egli, Riedel, Möller, Strauss & Läge, 2009; Läge, Egli, Möller & Riedel, 2012). Shortly afterwards, the team publishes another seminal study, marking their scientific breakthrough (Bühler, Keller & Läge, 2012). The project is subsequently funded by the Swiss Commission for Technology and Innovation (KTI).
Damian Läge founds Klenico AG with its headquarters in Zurich. Together with 18 leading experts, the Klenico system is being developed step by step. Parallel to the scientific research, the development of a software is initiated in order to make the principle of symptom maps applicable to psychiatric diagnostics.
With Richard Etter as CEO, the team is expanded by an experienced founder. The web-based software now encompasses the full range of psychopathological symptoms. The Klenico system receives approval as a medical product. Klenico AG successfully enters the market.